Psychedelic-Assisted Therapy Explained: How Therapists and Patients Work Together
Tell a Friend About This EventTell a Friend
 

Psychedelic-assisted therapy is showing promise for people who haven’t found mental health relief with traditional treatments. While it isn’t widely available yet, research suggests it will become more common in the near future.

10/1/2025
When: Wednesday, October 1, 2025
1:00 PM
Where: https://tinyurl.com/2af8chy2
United States

« Go to Upcoming Event List  

This webinar will help you understand what makes psychedelic-assisted therapy unique and why the relationship between patient and therapist is so important. You’ll learn how this approach differs from traditional talk therapy, what to expect as a patient, and how to recognize qualified and trustworthy therapists.

By the end, you’ll have practical information to guide your choices, whether you’re a patient curious about these treatments or a clinician interested in the future of care.

What You Will Learn

  • The Therapist’s Role: What therapists do before, during, and after psychedelic sessions.
  • The Patient’s Role: How patients prepare, participate, and follow up.
  • What to Look For: Skills, training, and qualities that make a strong psychedelic therapist.
  • The Big Picture: Current therapy options and what’s coming in the next few years.
Presenter(s) Biography

Jill M. Emanuele, PhD - ADAA Board Member

Jill Emanuele, PhD - ADAA Board Secretary

Jill M. Emanuele, PhD is Founder and Executive Director of Urban Yin Psychology, PLLC, based in New York City.  She previously served as Vice-President, Clinical Training and Senior Psychologist at the Child Mind Institute. She has a breadth of experience in the evaluation and treatment of children, adolescents, young adults, and adults with mood disorders, as well as the spectrum of psychiatric disorders, with a special focus on complex presentations. Dr. Emanuele has significant expertise in evidence-based treatments including cognitive behavioral therapy (CBT), dialectical behavior therapy (DBT), radically open DBT, family therapy and mindfulness training.  Furthermore, she has experience in global work through clinical implementation initiatives.  Dr. Emanuele has extensive experience in supervising clinicians and trainees in multiple disciplines and has served in multiple administrative leadership roles.  Furthermore, she has significant experience in developing clinical training programs that serve youth.

Dr. Emanuele completed her undergraduate studies with degrees in Psychology and Music from the University of Richmond, and her Ph.D. in clinical psychology from George Mason University.  She completed her predoctoral internship and postdoctoral fellowship in child and adolescent psychology at Long Island Jewish Medical Center (LIJ; now Northwell Health) in New York City, and has worked in several hospital settings including LIJ-Hillside Hospital, Montefiore Medical Center, and Bronx Children’s Psychiatric Center (now New York City Children’s Center).  Dr. Emanuele has presented at academic medical centers, professional conferences, public and private schools, and community organizations on the topics of mindfulness, adolescent depression and suicide, adolescent self-injury, DBT, and adolescent borderline personality disorder, and co-authored book chapters on some of these important topics.  She also provides education through multiple forms of media including television, radio, internet, and podcasts.  

Dr. Emanuele has been a member of ADAA since 2003 and has served in multiple capacities including the Chair of the Clinical Track for the Career Development Leadership Program (CDLP), the Conference Committee, and the Membership Committee. Dr. Emanuele joined the ADAA Board in 2022.  She now serves as Secretary for the Board.

Jonathan Schettino, PhD

Image of Jonathan Schettino, PhD

Dr. Jonathan Schettino is a licensed clinical psychologist in the State of Maryland. He completed his psychology training at Princeton University, the University of California, Los Angeles, and Otto-Friedrich University, Bamberg. He is the owner of PsychForward CBT, a Baltimore-based psychology group practice specializing in cognitive-behavioral therapy for anxiety disorders, OCD, and depression as well as psychological assessments for the workplace. Dr. Schettino also serves as a research psychologist at Johns Hopkins University Center for Psychedelics and Consciousness Research where he provides clinical consultation on psychedelic clinical trials, guides participants during psychedelic experiences, and studies the efficacy of psychedelics in the treatment of OCD as well as the role of the provider in psychedelic treatment modalities.